Filters

See more specimen types...

Other countries

Results: 1 to 20 of 29 (representing 18 labs)

Tests names and labsConditionsGenes and analytesMethods

OneOme RightMed pharmacogenomic test

OneOme
United States
9421
  • D Deletion/duplication analysis
  • T Targeted variant analysis

Psychiatric Medication Metabolism and Risk Factor

Molecular Diagnostics and Toxicology Laboratory
United States
33
  • T Targeted variant analysis

Comprehensive Medication Metabolism (no Risk factor)

Molecular Diagnostics and Toxicology Laboratory
United States
33
  • T Targeted variant analysis

Pain Medication Metabolism

Molecular Diagnostics and Toxicology Laboratory
United States
33
  • T Targeted variant analysis

Expanded Comprehensive Medication Metabolism

Molecular Diagnostics and Toxicology Laboratory
United States
77
  • T Targeted variant analysis

Comprehensive Medication Metabolism

Molecular Diagnostics and Toxicology Laboratory
United States
77
  • T Targeted variant analysis

Cardiac Medication Metabolism

Molecular Diagnostics and Toxicology Laboratory
United States
77
  • T Targeted variant analysis

CYP2C19

Genelex
United States
21
  • T Targeted variant analysis

CYP450 drug metabolizing enzyme mutation panel

Molecular Diagnostics Children's Hospital of Wisconsin
United States
33
  • D Deletion/duplication analysis
  • T Targeted variant analysis

CYP2C19 drug metabolizing enzyme gene mutation

Molecular Diagnostics Children's Hospital of Wisconsin
United States
11
  • T Targeted variant analysis

Clopidogrel response

Xcode Life Sciences
India
21
  • T Targeted variant analysis

Drug Metabolizing Enzymes and Transporters

Developmental and Neurogenetics Laboratory Medical College of Wisconsin
United States
33
  • T Targeted variant analysis

Drug Metabolism Test

Iowa Institute of Human Genetics University of Iowa
United States
42
  • T Targeted variant analysis

CYP2C19

Department of Laboratory Medicine P.D. Hinduja National Hospital - MRC
India
11
  • T Targeted variant analysis

Cytochrome P450 2C19, CYP2C19 - 9 Variants

ARUP Laboratories, Molecular Genetics and Genomics
United States
41
  • T Targeted variant analysis

Epilepsy Gene mutation panel

Molecular Diagnostics Children's Hospital of Wisconsin
United States
64
  • T Targeted variant analysis

Carisoprodol response

Xcode Life Sciences
India
11
  • T Targeted variant analysis

Susceptibility to Drugs , Sequencing CYP2C19 Gene

Reference Laboratory Genetics
Spain
11
  • C Sequence analysis of the entire coding region

Core DME Panel

Castle Medical Molecular Diagnostics Castle Medical, LLC
United States
22
  • T Targeted variant analysis

Pharmacogenetic panel

bio.logis Center for Human Genetics
Germany
4629
  • T Targeted variant analysis

Results: 1 to 20 of 29

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.

Support Center